Protective Effectiveness of Hantavirus Vaccine
A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overla...
Main Authors: | Keeho Park, Chang Soo Kim, Ki-Tae Moon |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2004-12-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/10/12/04-0684_article |
Similar Items
-
Progress on the Prevention and Treatment of Hantavirus Disease
by: Rebecca L. Brocato, et al.
Published: (2019-07-01) -
Hemorrhagic fever with renal syndrome and coexisting hantavirus pulmonary syndrome
by: Young Min Hong, et al.
Published: (2012-06-01) -
Hantaviruses in Serbia and Montenegro
by: Anna Papa, et al.
Published: (2006-06-01) -
Characterization of Hemorrhagic Fever with Renal Syndrome Caused by Hantaviruses, Estonia
by: Irina Golovljova, et al.
Published: (2007-11-01) -
Hantavirus Infection: a review and global update
by: Zhenqiang Bi, Pierre B.H. Formenty, Cathy E. Roth
Published: (2008-02-01)